183 related articles for article (PubMed ID: 15881418)
1. Prolonged allogeneic islet graft survival by protoporphyrins.
Pileggi A; Molano RD; Berney T; Ichii H; San Jose S; Zahr E; Poggioli R; Linetsky E; Ricordi C; Inverardi L
Cell Transplant; 2005; 14(2-3):85-96. PubMed ID: 15881418
[TBL] [Abstract][Full Text] [Related]
2. Prolonged Allogeneic Islet Graft Survival by Protoporphyrins.
Pileggi A; Molano RD; Berney T; Ichii H; Jose SS; Zahr E; Poggioli R; Linetsky E; Ricordi C; Inverardi L
Cell Transplant; 2005; 14(2-3):85-96. PubMed ID: 28871856
[TBL] [Abstract][Full Text] [Related]
3. Cobalt-protoporphyrin treatment enhances murine isoislets engraftment.
Fu SH; Hsu BR; Juang JH; Chen ST; Yang TY; Hsu S
Transplant Proc; 2004 Sep; 36(7):2205-6. PubMed ID: 15518801
[TBL] [Abstract][Full Text] [Related]
4. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
5. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
[TBL] [Abstract][Full Text] [Related]
6. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
7. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
8. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
[TBL] [Abstract][Full Text] [Related]
9. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
10. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of long-term cultured porcine islets in the rat: prolonged graft survival and recipient growth on reduced immunosuppression.
Rijkelijkhuizen JK; Töns A; Terpstra OT; Bouwman E
Cell Transplant; 2010; 19(4):387-98. PubMed ID: 20021733
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of rat islet xenografts in mice after CD45RB monotherapy.
Visser L; Poppema S; de Haan B; Klok P; van der Leij J; van den Berg A; de Vos P
Transplantation; 2004 Feb; 77(3):386-91. PubMed ID: 14966412
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
14. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
[TBL] [Abstract][Full Text] [Related]
15. Permanent acceptance of mitomycin C-treated islet allograft.
Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
[TBL] [Abstract][Full Text] [Related]
16. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.
Solari MG; Srinivasan S; Boumaza I; Unadkat J; Harb G; Garcia-Ocana A; Feili-Hariri M
J Autoimmun; 2009 Mar; 32(2):116-24. PubMed ID: 19217258
[TBL] [Abstract][Full Text] [Related]
17. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
Emamaullee JA; Stanton L; Schur C; Shapiro AM
Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
[TBL] [Abstract][Full Text] [Related]
18. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
19. Prolonged islet allograft survival by alpha-1 antitrypsin: the role of humoral immunity.
Molano RD; Pileggi A; Song S; Zahr E; San Jose S; Molina J; Fort A; Wasserfall C; Ricordi C; Atkinson MA; Inverardi L
Transplant Proc; 2008 Mar; 40(2):455-6. PubMed ID: 18374099
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.
Machen J; Bertera S; Chang Y; Bottino R; Balamurugan AN; Robbins PD; Trucco M; Giannoukakis N
Gene Ther; 2004 Oct; 11(20):1506-14. PubMed ID: 15229635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
